Harvest One Cannabis Inc. (TSX-V:HVT, OTCQB:HRVOF) CEO Gord Davey tells Proactive it has entered into a supply agreement with Canopy Growth Corporation (TSX:WEED, NYSE:CGC), strengthening its position in the cannabis-infused product market. Davey says through the agreement, Harvest One can sell its LivRelief Infused topical creams on the online medical store of Canopy's subsidiary, Spectrum Therapeutics, through an extension of its licensing agreement with Valens Agritech Ltd, a wholly-owned subsidiary of The Valens Company (TSX:VLNS, OTCQX:VLNCF)
Harvest One partners with Canopy Growth to sell LivRelief Infused Brand through their Spectrum Therapeutics Medical Group
